Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Cognetti

Showing results (11-20 of 275) with videos related to

Pageof 28
Sort By:
The New England Journal of Medicine|August 4, 2006
Lineage-specific hematopoietic growth factorsGianluigi Ferretti, Paola Papaldo, Francesco Cognetti
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2009
Darbepoetin alfa and history of thromboembolic eventsGianluigi Ferretti, Alessandra Felici, Francesco Cognetti
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2006
Is there a right-sided shift for colorectal cancer in women compared with men?Gianluigi Ferretti, Alessandra Felici, Francesco Cognetti, et al.
Anticancer Research|December 26, 2012
The Mammalian target of rapamycin inhibitors in breast cancer: current evidence and future directionsPaola Malaguti, Sabrina Vari, Francesco Cognetti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2007
Transforming growth factor-beta signaling and regulatory T cellsGianluigi Ferretti, Alessandra Felici, Francesco Cognetti, et al.
Journal of the National Cancer Institute|August 31, 2007
Re: Ovarian ablation or suppression in premenopausal early breast cancer: results from the International Adjuvant Breast Cancer Ovarian Ablation or Suppression randomized trialGianluigi Ferretti, Alessandra Felici, Paolo Carlini, et al.
Lancet (London, England)|May 15, 2007
Exemestane or tamoxifen?Gianluigi Ferretti, Alessandra Felici, Paolo Carlini, et al.
Journal of the National Cancer Institute|September 13, 2007
Re: Polychemotherapy for early breast cancer: results from the international adjuvant breast cancer chemotherapy randomized TrialGianluigi Ferretti, Alessandra Felici, Paolo Carlini, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 1, 2016
First-line therapy in HER2 positive metastatic breast cancer: is the mosaic fully completed or are we missing additional pieces?Alessandra Fabi, Paola Malaguti, Sabrina Vari, et al.
Melanoma Research|September 24, 2005
Central nervous system as exclusive site of disease in patients with melanoma: treatment and clinical outcome of two casesVirginia Ferraresi, Mariangela Ciccarese, Massimo Zeuli, et al.
Pageof 28

Showing results (11-20 of 275) with videos related to

Sort By:
Pageof 28
The New England Journal of Medicine|August 4, 2006
Lineage-specific hematopoietic growth factorsGianluigi Ferretti, Paola Papaldo, Francesco Cognetti
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2009
Darbepoetin alfa and history of thromboembolic eventsGianluigi Ferretti, Alessandra Felici, Francesco Cognetti
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2006
Is there a right-sided shift for colorectal cancer in women compared with men?Gianluigi Ferretti, Alessandra Felici, Francesco Cognetti, et al.
Anticancer Research|December 26, 2012
The Mammalian target of rapamycin inhibitors in breast cancer: current evidence and future directionsPaola Malaguti, Sabrina Vari, Francesco Cognetti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2007
Transforming growth factor-beta signaling and regulatory T cellsGianluigi Ferretti, Alessandra Felici, Francesco Cognetti, et al.
Journal of the National Cancer Institute|August 31, 2007
Re: Ovarian ablation or suppression in premenopausal early breast cancer: results from the International Adjuvant Breast Cancer Ovarian Ablation or Suppression randomized trialGianluigi Ferretti, Alessandra Felici, Paolo Carlini, et al.
Lancet (London, England)|May 15, 2007
Exemestane or tamoxifen?Gianluigi Ferretti, Alessandra Felici, Paolo Carlini, et al.
Journal of the National Cancer Institute|September 13, 2007
Re: Polychemotherapy for early breast cancer: results from the international adjuvant breast cancer chemotherapy randomized TrialGianluigi Ferretti, Alessandra Felici, Paolo Carlini, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 1, 2016
First-line therapy in HER2 positive metastatic breast cancer: is the mosaic fully completed or are we missing additional pieces?Alessandra Fabi, Paola Malaguti, Sabrina Vari, et al.
Melanoma Research|September 24, 2005
Central nervous system as exclusive site of disease in patients with melanoma: treatment and clinical outcome of two casesVirginia Ferraresi, Mariangela Ciccarese, Massimo Zeuli, et al.
Pageof 28